Medical imaging software vendor Merge Healthcare has retained investment bank Allen & Company to explore strategic alternatives “including, but not limited to, a sale of the company or a business combination,” according to the firm.
The stock price rose 9 percent in heavy early trading on Sept. 6 following the announcement, and the company will not comment further at this time. The announcement comes three weeks after Merge announced its new subscription-based revenue model is gaining traction among clients. In late July, the firm released second quarter financial results showing a 13 percent increase in revenue but a $5.9 million net loss, compared with a $1.7 million loss during the same period in 2011. During the first half of 2012, Merge’s revenue increased more than 14 percent to $123.9 million, but net losses more than doubled to $7.7 million.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access